John Grange

Q: What Schools Are Affiliated With John Grange

John Grange is affiliated with the following schools: Imperial College London, University College London, University of Oxford

John Grange 's AcademicInfluence.com Rankings

John Grange

Philosophy

#5950

World Rank

#8888

Historical Rank

Logic

#3151

World Rank

#4268

Historical Rank

philosophy Degrees

Download Badge

Philosophy

John Grange 's Degrees

Bachelors Medicine University of Oxford

Why Is John Grange Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Professor John Grange died 10 October 2016 was an English immunologist, epidemiologist, researcher, and academic, and was one of Europe's leading tuberculosis specialists. Education Grange was educated at Gresham's School, Holt, Norfolk, and then from 1962 to 1967 at the Middlesex Hospital Medical School of the University of London.

(See a Problem?)

John Grange 's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Zoonotic tuberculosis due to Mycobacterium bovis in developing countries. (1998) (937)
Antibacterial Properties of Propolis (Bee Glue) (1990) (416)
Mycobacterium bovis infection in human beings. (2001) (295)
Mycobacteria in water. (1984) (258)
Impact of HIV infection on tuberculosis (2000) (200)
The global burden of tuberculosis. (1999) (194)
Zoonotic aspects of Mycobacterium bovis infection. (1994) (174)
A study of maternal mortality at the University Teaching Hospital, Lusaka, Zambia: the emergence of tuberculosis as a major non-obstetric cause of maternal death. (1999) (144)
The global emergency of tuberculosis: what is the cause? (2002) (143)
Epidemiology of Mycobacterium bovis infection in animals and humans, with particular reference to Africa. (1995) (136)
The zoonotic importance of Mycobacterium bovis. (1996) (135)
The secreted antigens of Mycobacterium tuberculosis and their relationship to those recognized by the available antibodies. (1988) (131)
The meaning and structure of species as applied to mycobacteria. (1974) (129)
Activity of bromhexine and ambroxol, semi-synthetic derivatives of vasicine from the Indian shrub Adhatoda vasica, against Mycobacterium tuberculosis in vitro. (1996) (127)
The bovine tubercle bacillus. (1983) (122)
Tuberculosis bacteriology: organization and practice. (1997) (108)
A study of vitamin D levels in Indonesian patients with untreated pulmonary tuberculosis. (1985) (108)
Mycobacterium marinum infections in man (1985) (105)
Tuberculosis and the kidney. (2001) (103)
Guidelines for speciation within the mycobacterium tuberculosis complex (1996) (102)
Enzyme-linked immunosorbent assay (ELISA): a study of antibodies to Mycobacterium tuberculosis in the IgG, IgA and IgM classes in tuberculosis, sarcoidosis and Crohn's disease. (1980) (101)
Complications of bacille Calmette-Guérin (BCG) vaccination and immunotherapy and their management. (1998) (101)
Protection against melanoma by vaccination with Bacille Calmette-Guerin (BCG) and/or vaccinia: an epidemiology-based hypothesis on the nature of a melanoma risk factor and its immunological control. (2005) (100)
HIV/AIDS and its implications for the control of animal tuberculosis. (1993) (100)
T4 lymphopenia in patients with active pulmonary tuberculosis. (1985) (97)
Treatment of tuberculosis: present status and future prospects. (2005) (90)
Use of gene probes based on the insertion sequence IS986 to differentiate between BCG vaccine strains. (1992) (85)
Immunotherapy with Mycobacterium vaccae in patients with newly diagnosed pulmonary tuberculosis: a randomised controlled trial (1999) (81)
Mycobacterium avium. (2020) (80)
Collins and Lyne's microbiological methods. 6th edition. (1989) (79)
Possible improved survival of patients with stage IV AJCC melanoma receiving SRL 172 immunotherapy: correlation with induction of increased levels of intracellular interleukin-2 in peripheral blood lymphocytes. (1999) (77)
The bovine tuberculosis cycle--an African perspective. (1996) (76)
Inverse association between melanoma and previous vaccinations against tuberculosis and smallpox: results of the FEBIM study. (2002) (75)
The production and preliminary investigation of Burulin, a new skin test reagent for Mycobacterium ulcerans infection (1975) (75)
Clinically Significant Drug Interactions with Antituberculosis Agents (1994) (75)
Immunotherapy with Mycobacterium vaccae in the treatment of tuberculosis. (2004) (75)
Lung cancer risk: effect of dairy farming and the consequence of removing that occupational exposure. (2005) (74)
Mycobacteria and Human Disease (1996) (72)
Impact of vaccinations and infectious diseases on the risk of melanoma--evaluation of an EORTC case-control study. (2003) (72)
Subdivision of Mycobacterium tuberculosis into five variants for epidemiological purposes: methods and nomenclature (1982) (71)
Prior immunisation of patients with malignant melanoma with vaccinia or BCG is associated with better survival. An European Organization for Research and Treatment of Cancer cohort study on 542 patients. (2005) (70)
Bovine tubercle bacilli and disease in animals and man (1987) (67)
Total and anti-mycobacterial IgE levels in serum from patients with tuberculosis and leprosy. (1989) (67)
The mystery of the mycobacterial 'persistor'. (1992) (67)
The avian tubercle bacillus and its relatives. (1990) (66)
Tuberculosis. An interdisciplinary perspective (1999) (66)
Tuberculosis and cancer: parallels in host responses and therapeutic approaches? (1995) (65)
Subdivision of daughter strains of bacille Calmette-Guérin (BCG) according to secreted protein patterns. (1986) (64)
Successful immunotherapy with Mycobacterium vaccae in the treatment of adenocarcinoma of the lung. (2008) (64)
Organization and Practice in Tuberculosis Bacteriology (1987) (62)
Specificity of antibodies and tuberculin response after occupational exposure to tuberculosis. (1992) (61)
Tuberculosis in association with HIV/AIDS emerges as a major nonobstetric cause of maternal mortality in Sub‐Saharan Africa (2010) (61)
Bacteriologically confirmed non-tuberculous mycobacterial lymphadenitis in south east England: a recent increase in the number of cases. (1995) (61)
Paradox of the global emergency of tuberculosis (1999) (60)
Viewpoint: Scientific dogmas, paradoxes and mysteries of latent Mycobacterium tuberculosis infection (2011) (60)
Infections Caused by Opportunist Mycobacteria: A Review (1986) (59)
The mycobacteria: a sourcebook (1985) (59)
HIV-related tuberculosis due to Mycobacterium bovis. (1994) (59)
Is Africa lost? (1991) (58)
Common infectious agents in multiple sclerosis: a case—control study in children (2008) (54)
Detection of antituberculous activity in plant extracts. (1990) (54)
What is BCG? (1983) (53)
Pathogen-associated molecular pattern in cancer immunotherapy. (2008) (52)
Tuberculosis in disadvantaged groups (2001) (52)
Mycolic acid patterns of representative strains of Mycobacterium fortuitum, 'Myobacterium peregrinum' and Mycobacterium smegmatis. (1984) (51)
The use of mycobacterial adjuvant-based agents for immunotherapy of cancer. (2008) (51)
The biology of the genus Mycobacterium. (1996) (49)
Isolation and identification of micro-organisms of medical and veterinary importance (1985) (48)
The correlation of bacteriophage types of Mycobacterium tuberculosis with guinea-pig virulence and in vitro-indicators of virulence. (1978) (47)
Gamma interferon, but notMycobacterium leprae, induces major histocompatibility class II antigens on cultured rat Schwann cells (1987) (47)
The Evolution of Mycobacterial Disease in Human Populations: A Reevaluation [and Comments and Reply] (1987) (47)
Mycobacteria and the Skin (1982) (46)
Evaluation of healing by gentle touch in 35 clients with cancer. (2004) (46)
Diagnosis of active tuberculosis by immunological methods. 1. The effect of tuberculin reactivity and previous BCG vaccination on the antibody levels determined by ELISA. (1982) (45)
The rapid diagnosis of paucibacillary tuberculosis. (1989) (45)
Isolation of mycobacteria from patients seropositive for the human immunodeficiency virus (HIV) in south east England: 1984-92. (1993) (45)
Tuberculosis acquired in laboratories and necropsy rooms. (1999) (44)
Multidrug-resistant tuberculosis--can the tide be turned? (2001) (42)
Serodiagnostic tests for tuberculosis: a need for assessment of their operational predictive accuracy and acceptability. (1990) (42)
Campbell De Morgan's 'Observations on cancer', and their relevance today. (2002) (42)
A study of Mycobacterium fortuitum (ranae). (1974) (42)
Comparison of strains of Mycobacterium tuberculosis from British, Ugandan and Asian immigrant patients: a study in bacteriophage typing, susceptibility to hydrogen peroxide and sensitivity to thiophen-2-carbonic acid hydrazide. (1977) (42)
A study of acute-phase reactant proteins in Indonesian patients with pulmonary tuberculosis. (1984) (41)
Tuberculosis and the acquired immune deficiency syndrome. (1991) (40)
Immunological and clinical features of smear-positive pulmonary tuberculosis in East Java. (1980) (40)
A study of bovine strains of Mycobacterium tuberculosis isolated from humans in South-East England, 1977-1979. (1981) (40)
The cellular responses of tuberculosis and leprosy patients and of healthy controls in skin tests to 'new tuberculin' and leprosin A. (1986) (39)
The human dimension of tuberculosis control. (1993) (39)
The nature of mycobacterial disease in south east England, 1977-84. (1986) (39)
Reflections on the white plague. (2009) (38)
Factors affecting susceptibility and resistance to tuberculosis. (2001) (38)
Infection and disease caused by environmental mycobacteria (2002) (37)
Expression of major histocompatibility complex class I and class II antigens in human Schwann cell cultures and effects of infection with Mycobacterium leprae. (1987) (35)
Bacteriological survey of tuberculous lymphadenitis in South-east England: 1973-80. (1982) (35)
Isolation of environmental mycobacteria from clinical specimens in south-east England: 1973-1993. (1997) (35)
The humoral immune response in tuberculosis: its nature, biological role and diagnostic usefulness. (1984) (34)
A comparison of the responsiveness to four new tuberculins among Indonesian patients with pulmonary tuberculosis and healthy subjects. (1986) (34)
Does immunotherapy with heat-killed Mycobacterium vaccae offer hope for the treatment of multi-drug-resistant pulmonary tuberculosis? (2001) (34)
Role of lipid content and hydrogen peroxide susceptibility in determining the guinea-pig virulence of Mycobacterium tuberculosis. (1982) (33)
Is the risk of multiple sclerosis related to the ‘biography’ of the immune system? (2009) (33)
The genetics of mycobacteria and mycobacteriophages - a review. (1975) (33)
The Koch phenomenon and delayed hypersensitivity: 1891-1991. (1991) (32)
The tuberculosis pandemic: implications for health in the tropics. (1999) (31)
The tuberculosis pandemic--which way now? (1999) (30)
Healing by Gentle Touch Ameliorates Stress and Other Symptoms in People Suffering with Mental Health Disorders or Psychological Stress (2006) (30)
Environmental mycobacteria and BCG vaccination. (1986) (30)
The specificity of the humoral immune response to soluble mycobacterial antigens in tuberculosis. (1980) (30)
Infection and disease due to the environmental mycobacteria. (1987) (30)
Incidence and nature of human tuberculosis due to Mycobacterium africanum in South-East England: 1977–87 (1989) (29)
The politics of tuberculosis: the role of process and power. (1999) (28)
Historical declines in tuberculosis: nature, nurture and the biosocial model. (2001) (28)
BCG vaccination and cancer. (1990) (28)
A case report of Mycobacterium chelonae keratitis and a review of mycobacterial infections of the eye and orbit. (1994) (27)
Tuberculosis: A Foundation for Nursing and Healthcare Practice (2005) (27)
Tuberculosis and the poverty-disease cycle (1999) (27)
Impairment of vasomotor reflexes in the fingertips of leprosy patients. (1991) (26)
Incidence and nature of human tuberculosis due to bovine tubercle bacilli in South-East England: 1977–1987 (1988) (26)
Science, medicine, and the future: Tuberculosis (1998) (26)
Appraisal of the monoclonal antibody-based competition test for the serology of tuberculosis in Indonesia (1987) (25)
Use of umbelliferone derivatives in the study of enzyme activities of mycobacteria. (1977) (25)
Fluorimetric assay of mycobacterial group-specific hydrolase enzymes. (1978) (24)
"Classical" and "Asian" variants of Mycobacterium tuberculosis isolated in South East England 1977-1980. (1982) (24)
Evaluation of healing by gentle touch. (2005) (24)
The way forward: an integrated approach to tuberculosis control. (1999) (24)
The promise of immunotherapy for tuberculosis. (1994) (23)
Doing something about tuberculosis (1999) (23)
The Mantoux test in tuberculosis: correlations between the diameters of the dermal responses and the serum protein levels. (1981) (23)
Identification and characteristics of Mycobacterium bovis isolated from cattle, badgers and deer in the Republic of Ireland. (1990) (23)
A bacteriological survey of tuberculosis due to the human tubercle bacillus (Mycobacterium tuberculosis) in South-East England: 1984–91 (1993) (23)
Reevaluation of Mycobacterium fortuitum (Synonym: Mycobacterium ranae) (1974) (22)
Bacteriological survey of tuberculous lymphadenitis in southeast England, 1981-1989. (1992) (22)
Infection, inflammation and cancer (2011) (22)
Mycobacterium vaccae immunotherapy (1991) (22)
Tuberculosis and tubulointerstitial nephritis: an intriguing puzzle. (2011) (22)
Old plague, new plague, and a treatment for both? (1993) (21)
The Genetics of Host Resistance and Susceptibility to Tuberculosis (2001) (21)
Immune protection against tuberculosis--when is immunotherapy preferable to vaccination? (2011) (20)
Multiple Sclerosis: Are Protective Immune Mechanisms Compromised by a Complex Infectious Background? (2010) (20)
Diagnosis of active tuberculosis by immunological methods. 2. Qualitative differences in the dermal response to tuberculin in patients with active pulmonary disease and healthy tuberculin-positive individuals. (1982) (20)
Making DOTS succeed (1997) (20)
Haptoglobin: an immunoregulatory role in tuberculosis? (1985) (20)
The common mycobacterial antigens and their importance in the treatment of disease. (2009) (19)
Melanoma, Darwinian medicine and the inner world (2010) (19)
Bacteriophage typing of Mycobacterium tuberculosis strains isolated in South East England. (1976) (19)
Paradigms in multiple sclerosis: time for a change, time for a unifying concept (2011) (18)
The biography of the immune system and the control of cancer: from St Peregrine to contemporary vaccination strategies (2014) (18)
Tuberculosis Control in India. A State-of-the-Art Review. J. Ogden, S. Rangan and S. Lewin (editors). London: London School of Hygiene and Tropical Medicine, 1999. 112 pp. Price £2.00 (UK) and £3.00 (elsewhere) (1999) (18)
Impairment of fingertip vasomotor reflexes in leprosy patients and apparently healthy contacts. (1991) (17)
Is the incidence of AIDS-associated Mycobacterium avium-intracellulare disease affected by previous exposure to BCG, M. tuberculosis or environmental mycobacteria? (1994) (17)
Early delayed hypersensitivity responses in tuberculin skin tests after heavy occupational exposure to tuberculosis. (1991) (17)
Phage typing of Mycobacterium kansasii. (1980) (16)
Subdivision of Mycobacterium tuberculosis for epidemiological purposes: a seven year study of the ‘Classical’ and ‘Asian’ types of the human tubercle bacillus in South-East England (1985) (16)
Diversity in migration of CD4 and CD8 lymphocytes in different microanatomical compartments of the skin in the tuberculin reaction in man. (1988) (16)
Establishing a united front against the injustice of tuberculosis. (1998) (15)
A study of the relationship between the resistance of Mycobacterium tuberculosis to isonicotinic acid hydrazide (isoniazid) and to thiophen-2-carboxylic acid hydrazide. (1984) (15)
Serological tests for tuberculosis: can the problem of low specificity be overcome? (1982) (15)
'Uber tuberkulose'. A tribute to Robert Koch's discovery of the tubercle bacillus, 1882. (1982) (15)
Koch's Tubercle Bacillus - a centenary reappraisal. (1982) (15)
Host-phage relationships in the genus Mycobacterium and their clinical significance. (1978) (14)
Cold fingers in leprosy. (1992) (14)
Relationship between radiological classification and the serological and haematological features of untreated pulmonary tuberculosis in Indonesia. (1989) (14)
Histometric studies on biopsies of tuberculin skin tests showing evidence of ischaemia and necrosis (1989) (14)
Therapeutic vaccination for cancer : the potential value of mycobacterial products (1999) (14)
Determinants of the tuberculosis burden in populations. (1999) (14)
The nature and incidence of lysogeny in Mycobacterium fortuitum. (1975) (14)
Socio-cultural dimensions in tuberculosis control. (1999) (14)
Effect of the method of preparation of bacille Calmette-Guérin (BCG) vaccine on the properties of four daughter strains. (1987) (13)
Therapeutic vaccines. (1996) (13)
Non-tuberculous mycobacterial pulmonary infections. (2002) (13)
Mycobacterial infections following heart valve replacement. (1992) (13)
Chronic inflammation as a manifestation of defects in immunoregulatory networks: implications for novel therapies based on microbial products (2009) (13)
Immunotherapy for malignant melanoma--tracing Ariadne's thread through the labyrinth. (2009) (13)
Mycobacterium chelonei. (1981) (13)
A scientific appraisal (2002) (13)
Differentiation of BCG from other variants of Mycobacterium tuberculosis isolated from clinical material. (1978) (12)
A study of the effects of intradermal administration of recombinant gamma interferon in lepromatous leprosy patients. (1987) (12)
Immunological techniques in microbiology (1987) (12)
Infections caused by opportunistic mycobacteria: a review (1986) (12)
Advances in the management of tuberculosis: clinical trials and beyond (2000) (12)
A fluorigenic substrate for the rapid differentiation of Mycobacterium fortuitum from Mycobacterium chelonei on the basis of heat stable esterase activity. (1977) (11)
Factors determining ethnic differences in the incidence of bacteriologically confirmed genitourinary tuberculosis in south east England. (1995) (11)
The Relation between Cutaneous Blood Flow and Cell Content in the Tuberculin Reaction (1989) (11)
Environmental Echoes (2001) (11)
The biosocial dynamics of tuberculosis (2009) (11)
Molecular biology: new hopes and challenges. (1988) (11)
Is a hypothetical melanoma-like neuromelanin the underlying factor essential for the aetiopathogenesis and clinical manifestations of multiple sclerosis? (2013) (10)
Virulence of Mycobacterium tuberculosis (1985) (10)
Clinical aspects of mycobacterial disease (1989) (10)
Vaccination Strategies to Reduce the Risk of Leukaemia and Melanoma (2003) (10)
Environmental mycobacteria and human disease. (1991) (10)
Qualitative differences in tuberculin reactivity in patients with tuberculosis, occupational contacts and non-contacts. (1984) (10)
Drug resistance and tuberculosis elimination. (1990) (10)
Chapter 6 – The genus Mycobacterium and the Mycobacterium tuberculosis complex (2009) (10)
Immunotherapy: a new strategy for tuberculosis control? (1997) (9)
Scientific dogmas, paradoxes and mysteries of latent Mycobacterium tuberculosis infection (2010) (9)
Tuberculosis in high-prevalence countries: current control strategies and their technical and operational limitations. (1999) (9)
Fluorigenic glycosidase substrates: their use in the identification of some slow growing mycobacteria. (1979) (9)
Vaccination strategies to reduce the risk of leukaemia and melanoma. (2003) (9)
Latest developments in the control of postharvest decay of citrus fruit in South Africa. (1983) (9)
Enzymic breakdown of amino acids and related compounds by suspensions of washed mycobacteria. (1976) (9)
Bacteriophage typing of Mycobacterium ranae (Fortuitum). The use of unadapted and adapted phages in the development of a typing system. (2009) (9)
Delayed hypersensitivity and HLA in smear-positive pulmonary tuberculosis. (1995) (9)
Can prior vaccinations against certain infections confer protection against developing melanoma? (2009) (9)
Skin test responsiveness to four new tuberculins in patients with chronic obstructive airways disease receiving short term high doses of, or long term maintenance treatment with, prednisolone: clinical appearances and histometric studies. (1987) (8)
The Society for Applied Bacteriology Technical Series (1990) (8)
Therapy of infections caused by 'atypical' mycobacteria. (1984) (8)
Mycobacteria in relation to tissue immune response and pathogenesis (1993) (8)
A clinical evaluation of the diagnostic usefulness of an early dermal reaction to tuberculin: a failure to distinguish between tuberculosis and other respiratory disease. (1985) (8)
Public health and human rights: the ethics of international public health interventions for tuberculosis. (1999) (8)
Unusual opportunist mycobacteria. (1986) (8)
ANTIBODIES TO MYCOBACTERIUM TUBERCULOSIS IN LEPROSY (1987) (8)
The potential use of DNA probes to identify and type strains within the Mycobacterium tuberculosis complex (1989) (8)
Human and bovine tuberculosis--new threats from an old disease. (1996) (8)
Microdose-mediated immune modulation (1993) (7)
Corticosteroids as a risk factor for tuberculosis. (1993) (7)
Serum angiotensin-converting enzyme and delayed hypersensitivity in pulmonary tuberculosis. (1984) (7)
Lymphocyte and lymphocyte subset numbers in blood and bronchoalveolar lavage and pleural fluid in various forms of human pulmonary tuberculosis. (1992) (7)
Immunotherapy of tuberculosis. (1990) (7)
The endocrine system and the immune response: prospects for novel therapeutic approaches (1996) (7)
New Concepts for the Control of Tuberculosis in the 21st Century (1993) (7)
Bacteriophage typing of Mycobacterium ranae (Fortuitum). The correlation of lysis by mycobacteriophage BK4 and inositol utilisation. (2009) (7)
Dogma and Innovation in the Global Control of Tuberculosis: Discussion Paper (1994) (7)
The method of preparation of an antigen may influence the cellular reaction to it in skin tests for delayed hypersensitivity: comparison between responses to two different reagents prepared from Mycobacterium tuberculosis. (1987) (7)
Genetic manipulation: techniques and applications. (1991) (7)
Mycobacterium tuberculosis: the organism (2008) (7)
Composition and Size of Shope Fibroma Virus Deoxyribonucleic Acid (1972) (7)
Effective vaccination against tuberculosis—a new ray of hope (2000) (7)
Tuberculosis in ethnic minority populations in industrialised countries. (1999) (7)
Survey of mycobacteria isolated from urine and the genitourinary tract in south-east England from 1980 to 1989. (1992) (6)
Diagnostic tests for tuberculosis and their evaluation. (1994) (6)
Nomenclature of mycobacterial disease. (1989) (6)
Vaccination against tuberculosis : Past problems and future hopes (1997) (6)
Measurements of blood flow and histometry of the cellular infiltrate in tuberculin skin test responses of the typical Koch type and the non-turgid variant form (Listeria-type) in pulmonary tuberculosis patients and apparently healthy controls. (1992) (6)
Serum phosphorus levels in pulmonary tuberculosis. (1984) (6)
New approaches to the diagnosis of tuberculosis in childhood with special reference to neurotuberculosis (1990) (6)
Quality control of homoeopathic medicines (1992) (6)
Kanamycin and neomycin resistance in Mycobacterium ranae (fortuitum) associated with serological and biochemical markers. (1974) (6)
The effect of exposure of hospital employees to patients with tuberculosis on dermal reactivity to four new tuberculins. (1986) (6)
The economics of tuberculosis diagnosis and treatment. (1999) (6)
Tuberculosis and HIV: light after darkness. (1994) (6)
Gender issues in the detection and treatment of tuberculosis. (1999) (6)
BOVINE TUBERCULOSIS : RESERVOIRS AND SOURCES OF INFECTION (1996) (6)
The biology of the mycobacteria. Vol. 3. Clinical aspects of mycobacterial disease. (1989) (6)
World TB Day 2010 – New innovations are required for enhancing the global fight against Tuberculosis: the ‘Captain of all these men of death’ (2010) (5)
Immunotherapy for Tuberculosis (1994) (5)
Heat-stable opsonins in tuberculosis and leprosy. (1993) (5)
The ‘Global Emergency’ of Tuberculosis (1999) (5)
Demystifying the control of tuberculosis in rural Bangladesh. (1998) (5)
DOTS and beyond: towards a holistic approach to the conquest of tuberculosis. (1997) (5)
Pathogenesis of Mycobacterial Disease (1998) (5)
Specific antibody in the subclasses of immunoglobulin G in patients with smear-positive pulmonary tuberculosis. (1987) (5)
DOTS with a SMILE. (1999) (4)
Microbial Diseases of Occupations, Sports and Recreations (1996) (4)
Intra-specific variation in the mycobacteria. A taxonomic aid. (1973) (4)
Educational approaches in tuberculosis control: building on the 'social' paradigm. (1999) (4)
The microbiological hazards of occupations. (1990) (4)
Names for mycobacteria. (1984) (4)
The "Asian" type of Mycobacterium tuberculosis. (1982) (4)
Strain to strain variation in the immunogenicity of BCG. (1986) (4)
Human endogenous retroviruses in health and disease. (2005) (4)
Names for mycobacteria. (1984) (4)
Community-based interventions to reduce maternal mortality (2010) (4)
Is the eradication of tuberculosis 'yesterday's ambition' or 'tomorrow's triumph'? (2010) (4)
Leprosy of the past and today. (2004) (4)
Association between Km1 immunoglobulin allotype and pulmonary tuberculosis in Indonesians. (1987) (4)
Paradox of the global emergency of tuberculosis : Tuberculosis progress report (1999) (4)
Mycobacterial disease—a challenge to biotechnology (1985) (4)
Pseudolysogeny in Mycobacterium diernhoferi ATCC19341. (1975) (4)
Biblical ills and remedies. (1987) (3)
Proceedings: Bacteriophage typing of strains of Mycobacterium tuberculosis isolated in south-east england. (1975) (3)
Tuberculosis: the changing tubercle. (1979) (3)
Lysogeny associated with mucoid variation in Mycobacterium kansasii. (1978) (3)
Failure to detect homology between the DNA of the Shope fibroma virus and the DNA of the sensitive cell. (1971) (3)
Mycobacterial pathogenicity and nomenclature: the 'nyrocine mycobacteria'. (1983) (3)
Drug sensitivity tests (1985) (3)
A micromethod for the study of n-paraffin utilization by mycobacteria. (1974) (3)
Tuberculosis and Environmental (Atypical) Mycobacterioses: Bacterial Pathological and Immunological Aspects (1989) (3)
Spirituality in patient care. why, how, when and what. Harold G. Koenig 2002. Philadelphia & London: Temple Foundation Press. ISBN 189015189‐0 (2002) (3)
Thenatureofmycobacterial disease insoutheast England, 1977-84 (1986) (3)
Childhood infectious diseases and risk of leukaemia in an adult population (2014) (3)
Tuberculosis — An Epidemic of Injustice (1997) (3)
Bacteriologically proven tuberculosis meningitis in South-East England: 1984-91. (1994) (3)
Tuberculosis and health sector reform. (1999) (3)
Lupus and lepros. (1988) (3)
Vaccination, infection, and the risk for multiple sclerosis. (2015) (3)
Role of viral infections in the inception of childhood asthma and allergies. (1995) (3)
The changing tubercle (1991) (3)
Introduction: mycobacteria and mycobacterial disease (1985) (2)
Infection, vaccination and protection against melanoma - a ray of hope for novel preventive and therapeutic strategies? (2005) (2)
Tuberculosis and HIV - perspectives from sub-Saharan Africa. (1999) (2)
Inhibition of T cell proliferation by human alveolar macrophages (1998) (2)
Reply: honey and propolis as possible promoters of the healing of ulcers in leprosy. (1990) (2)
A critique of the global effort: do tuberculosis control programmes only exist on paper? - a perspective from a developing country. (1999) (2)
The serodiagnosis of tuberculosis: a comparison of an enzyme-linked immunosorbent assay and a solid-phase radioimmunoassay. (1988) (2)
Julian of Norwich ‐ her relevance to healing today (2003) (2)
Identification of ‘other mycobacteria’ (1985) (2)
CD4+ T-lymphocytopenia in pulmonary tuberculosis. (1998) (2)
Failure rate distribution of electronic components (1970) (2)
Bacteriologically proven tuberculous meningitis in South-East England: 1984–1991 (1994) (2)
Natural Medicine from Honey Bees (1992) (2)
Occupational exposure to Mycobacterium tuberculosis and cytology of response to skin testing with 'New Tuberculin'. (1987) (2)
Study on the Validity of Electronic Parts Stress Models (1971) (2)
Bovine tuberculosis in Africa. (2005) (2)
Making DOTS succeed. Directly Observed Treatment, Short Course. (1997) (2)
Aetiology of childhood leukemia. (1994) (2)
Campbell De Morgan's ‘Observations on Cancer’, and their Relevance Today (2002) (2)
Anti-tuberculosis agents (2003) (2)
Recent developments in molecular biology of mycobacteria. (1990) (2)
GLOBALIZATION, HEALTH SECTOR REFORM AND JUSTICE (2001) (2)
New Intermetallic Compounds in Zircaloy-4 (1982) (2)
Infection with non-tuberculous mycobacteria. (1995) (2)
Prevention of tuberculosis and leprosy (1988) (1)
Regional variations in serum immunoglobulin levels in South East Asia. (1983) (1)
Pathogenesis of tuberculosis: pathway to apical localization. (1995) (1)
Applying human rights to tuberculosis control. (1999) (1)
Tuberculosis and the cow (1997) (1)
Anti-tuberculosis drugs (Handbook of Experimental Pharmacology, Vol. 84) (1988) (1)
MYCOBACTERIAL CULTURE: WHAT TEMPERATURE? (1988) (1)
Relationship between immunoglobulin levels, tuberculin hypersensitivity and radiological extent of disease in Greek patients with pulmonary tuberculosis. (1989) (1)
Disease caused by environmental mycobacteria (2010) (1)
Erasures from the “Register” (1972) (1)
CHAPTER 33 – Antimycobacterial agents (2010) (1)
Transmission of bovine TB in cattle: a critical reappraisal (1999) (1)
Mycobacterium vaccae immunotherapy. Author's replies (1991) (1)
Identification of species and variants of tubercle bacilli (1985) (1)
Immunotherapy for Cancer (2002) (1)
Quality control of homoeopathic medicines (1992) (1)
Prophylactic intervention for childhood leukaemia. (2011) (1)
Chemoprophylaxis for tuberculosis. (1993) (1)
Chapter 15 – Human tuberculosis due to Mycobacterium bovis and related animal pathogens (2009) (1)
Mycobacterial disease--old problems, new solutions. (1996) (1)
Haptoglobin polymorphism in tuberculosis. (2000) (1)
Increased Sensitivity to Vitamin D in Tuberculosis (1986) (1)
Cooperative studies on the immunology of tuberculosis at Airlangga University, Surabaya, Indonesia. (1990) (1)
Points: The future of BCG vaccination (1986) (1)
Current trends in the management of tuberculosis. (1994) (1)
Application of bacteriophage typing to studies on the epidemiology of tuberculosis in Asian immigrants resident in Great Britain. (1978) (1)
Immune protection against leukaemia (2017) (1)
Tuberculosis and Co-infection with the Human Immunodeficiency Virus (2004) (1)
The biography of the immune system and the control of cancer: from St Peregrine to contemporary vaccination strategies (2014) (1)
What's in a name ... TB or not TB? (1997) (1)
The time-table of tuberculosis. (1995) (1)
18 – Mycobacterium: Tuberculosis; leprosy (2012) (1)
Fine Pitch Wire Bonding for µBGA™ Packages (1995) (0)
Re-emergence of tuberculosis. (1993) (0)
Microelectronic bond connection with conductor motion (1995) (0)
A response by nurses to the challenge of tuberculosis in the United Kingdom and Russia. (1999) (0)
complex class Iand class IIantigens inhumanSchwann cell cultures and effects ofinfection withMycobacterium leprae (1987) (0)
DOTS? But we can't implement it! (1997) (0)
Ancient Retrovirus Targeted by Engineered T Cells in Melanoma—Letter (2015) (0)
Taxonomic principles – the basis of identification (1985) (0)
Complementary medicine (1990) (0)
The role and scope of the tuberculosis laboratory in human and veterinary medicine and epidemiology (1985) (0)
Comment: Persistence of Mycobacterium leprae in the peripheral nerves of multidrug-treated leprosy patients. (1993) (0)
Serumphosphorus levels inpulmonary tuberculosis (1984) (0)
Tuberculosis (1998) (0)
Letters to the Editor (1983) (0)
During the eight years 1973-80 the Public Health Laboratory Service Regional Centre for Tuberculosis (0)
SHOPE FIBROMA VIRUS DNA Materials and Methods , when purified vaccinia and (0)
Human Endogenous Retroviruses in Health and Disease (2005) (0)
The third biovariant of Mycobacterium fortuitum. (1993) (0)
New intermetallic compounds in Zircaloy-4. Discussion (1982) (0)
MYCOBACTERIUM XENOPI AND BCG, PATHOGENS OF THE FUTURE? (1985) (0)
' s response to reviews Title : Is a hypothetical melanoma-like neuromelanin the underlying factor essential for the clinical manifestation of multiple sclerosis ? (0)
The British Royal Commission on Tuberculosis. (2007) (0)
Infections Caused by Opportunistic Mycobacteria (1987) (0)
Examination of direct smears (1985) (0)
Comprar Immunological Techniques in Microbiology | Sheila M. Ross | 9780632019083 | Wiley (2009) (0)
Protection in the (farm) dust. (2005) (0)
Re-emergence of tuberculosis. (1993) (0)
Comprar 100 Questions and Answers About Hypertension | J. M. Grange | 9780632044818 | Wiley (2009) (0)
Complementary Medicine in the Medical Curriculum (1997) (0)
Calculation of the attenuation error of a ladder network with respect to the adjustment tolerances of tantalum nitride resistors (1968) (0)
Thomas Welwyn Osborn (2004) (0)
Letters to the Editor (1996) (0)
Human Disease due to Environmental Mycobacteria (2003) (0)
Preferred Titles (2006) (0)
DISEASE OF THE MONTH (2001) (0)
New approaches to the study of enzyme activity in mycobacteria. (1978) (0)
Abdominal tuberculosis(TB)-A single centre study in inner london, united kingdom (2000) (0)
Letters 134 (2005) (0)
Animal inoculation and assay tests (1985) (0)
Inflammatory bowel disease (1994) (0)
Serum vitamin D and calcium in tuberculous patients (1986) (0)
Humoral immune response in infants after Bacillus Calmette-Guerin (BCG) vaccination. (1996) (0)
Chapter 143 – Antituberculosis agents (2010) (0)
Notification of tuberculosis: how many cases are never reported? (1993) (0)
The organization of tuberculosis laboratory services (1985) (0)
' s report Title : The biography of the immune system and the control of cancer : from St Peregrine to contemporary vaccination strategies Version : 1 (0)
DOTS--keep on smiling. (2003) (0)
Galloping consumption. (1998) (0)
Is the increase in tuberculosis an epidemic. (1994) (0)
Ultrastructure of human foetal Schwann cells in tissue culture infected with Mycobacterium leprae. (1988) (0)
Recent European research activities in mycobacteriology. (1980) (0)
The computer as an aid to the system reliability engineer (1969) (0)
[Is bacteriophage typing of Mycobacterium tuberculosis of practical value?]. (1978) (0)
Microbe dependence of Mycobacterium leprae: a possible intracellular relationship with protozoa. (1987) (0)
[Epidemiology of tuberculosis]. (2004) (0)
Antibacterial activity [against Mycobacterium tuberculosis] of extracts and constituents of Piper nigrum and Galipea officinalis (1994) (0)
20 – Actinomyces, nocardia and tropheryma: Actinomycosis; nocardiasis; Whipple's disease (2012) (0)
Healing for cancer in a community setting (2010) (0)
Miss, Mister, Doctor. Preferred titles. (2006) (0)
Effects of the Coupling Between Components of the Reliability of an Integrated Function (1970) (0)
A mixed-method approach evaluating the impact of healing for cancer (2010) (0)
Reductionism (1997) (0)
Isolation ofmycobacteria frompatients seropositive forthehumanimmunodeficiency virus (HIV)insouth eastEngland: 1984-92 (2011) (0)
Olmsted's Syndrome (1997) (0)
The occurrence and detection of lysogeny in the genus Mycobacterium. (1975) (0)
Precision of reliability estimations (1970) (0)
“Opportunist” mycobacterial infections (2000) (0)
Is tuberculosis prophylaxis necessary for patients receiving corticosteroids for respiratory disease? (1994) (0)
Collection, preservation and transport of specimens (1985) (0)
What do we mean by Christian healing (2002) (0)
Would you know one if you met one? (2001) (0)
The transcendence of eternity (2005) (0)
fingertips of leprosy patients . Impairment of vasomotor reflexes in the (0)
19 – Environmental mycobacteria: Opportunist disease (2012) (0)
Points: Pre-employment chest radiographs (1988) (0)
Impairment ofvasomotorreflexes inthe fingertips ofleprosy patients (1991) (0)

This paper list is powered by the following services:

Other Resources About John Grange

en.wikipedia.org

What Schools Are Affiliated With John Grange ?

John Grange is affiliated with the following schools:

John Grange 's Academic­Influence.com Rankings